InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by McKhann Chas, Chairman & CEO. Insider active across 3 companies, notably Apollo Endosurgery, Inc.. Cumulatively, 10 filings have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €594k. History available since 18 August 2021. The latest transaction was disclosed on 1 March 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations10 total
722,396 sharesCommon StockSEC:0001140361-24-041406:0
110,313 shares0Common StockSEC:0001593968-24-000432:0
612,083 shares0Common StockSEC:0001593968-23-001398:0
689,880 sharesCommon StockSEC:0001251769-23-000027:0
112,607 shares0Common StockSEC:0001251769-22-000053:0
66,553 shares@ US$5.4236.6% of flowCommon StockSEC:0001251769-22-000036:0
21,156 shares@ US$8.2115.9% of flowCommon StockSEC:0001251769-21-000107:0
21,156 shares@ US$8.2115.9% of flowCommon StockSEC:0001251769-21-000105:0
21,156 shares@ US$8.2115.9% of flowCommon StockSEC:0001251769-21-000105
21,156 shares@ US$8.2115.9% of flowCommon StockSEC:0001251769-21-000107
10 of 10 declarations
About McKhann Chas
Chas McKhann is the Chief Executive Officer of Apollo Endosurgery, Inc. He leads the company with a focus on innovation in the field of medical devices. His leadership is essential for the development and implementation of new health solutions.
